Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-02

Clinical Trial Update: Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating inguinal node-sparing radiotherapy for patients with early-stage anal canal cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Anal Canal Cancer | Phase 2 | Status: RECRUITING